全文获取类型
收费全文 | 40768篇 |
免费 | 2285篇 |
国内免费 | 166篇 |
专业分类
耳鼻咽喉 | 449篇 |
儿科学 | 884篇 |
妇产科学 | 736篇 |
基础医学 | 7804篇 |
口腔科学 | 846篇 |
临床医学 | 3272篇 |
内科学 | 7432篇 |
皮肤病学 | 1050篇 |
神经病学 | 4395篇 |
特种医学 | 1957篇 |
外国民族医学 | 1篇 |
外科学 | 5428篇 |
综合类 | 203篇 |
一般理论 | 14篇 |
预防医学 | 2026篇 |
眼科学 | 885篇 |
药学 | 2906篇 |
中国医学 | 33篇 |
肿瘤学 | 2898篇 |
出版年
2021年 | 405篇 |
2020年 | 354篇 |
2019年 | 600篇 |
2018年 | 691篇 |
2017年 | 531篇 |
2016年 | 732篇 |
2015年 | 832篇 |
2014年 | 1000篇 |
2013年 | 1448篇 |
2012年 | 2055篇 |
2011年 | 2192篇 |
2010年 | 1479篇 |
2009年 | 1392篇 |
2008年 | 2311篇 |
2007年 | 2365篇 |
2006年 | 2225篇 |
2005年 | 2303篇 |
2004年 | 2154篇 |
2003年 | 2163篇 |
2002年 | 2257篇 |
2001年 | 463篇 |
2000年 | 416篇 |
1999年 | 530篇 |
1998年 | 635篇 |
1997年 | 500篇 |
1996年 | 365篇 |
1995年 | 395篇 |
1994年 | 341篇 |
1993年 | 315篇 |
1992年 | 277篇 |
1991年 | 272篇 |
1990年 | 248篇 |
1989年 | 233篇 |
1988年 | 235篇 |
1987年 | 192篇 |
1985年 | 213篇 |
1984年 | 223篇 |
1983年 | 221篇 |
1982年 | 244篇 |
1981年 | 215篇 |
1980年 | 167篇 |
1978年 | 181篇 |
1976年 | 167篇 |
1933年 | 193篇 |
1932年 | 219篇 |
1931年 | 193篇 |
1930年 | 183篇 |
1929年 | 167篇 |
1928年 | 180篇 |
1926年 | 169篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
1.
Noreen M. Walsh Heinz Kutzner Luis Requena Lorenzo Cerroni 《Journal of cutaneous pathology》2019,46(9):698-708
We review the spectrum of cutaneous disorders associated with inflammatory and neoplastic plasmacytic pathology. Because plasma cells are derived from B‐lymphocytes our overview includes discussion of certain lymphoplasmacytic proliferations. It is structured along histopathological lines, addressing conditions characterized by (a) cutaneous plasma cell infiltrates, (b) deposits of plasma cell products or their derivatives in the skin and (c) miscellaneous, poorly understood cutaneous complications of plasmacytic disorders. Lesions arising primarily in the skin and those due to cutaneous involvement by multisystem disorders are addressed. The range includes a spectrum of tumefactive and circulatory manifestations. We highlight key clinical and pathological features of the different conditions and outline recent advances in our understanding of these entities. By emphasizing the dermatopathological characteristics of this spectrum of disorders we hope to hone the diagnostic accuracy of practitioners in the field. 相似文献
2.
3.
Well‐being,health and fitness of children who use wheelchairs: Feasibility study protocol to develop child‐centred ‘keep‐fit’ exercise interventions 下载免费PDF全文
4.
Baettig Linda Baeumelt Andreas Ernst Jutta Boeker Heinz Grimm Simone Richter Andre 《Brain imaging and behavior》2020,14(6):2073-2083
Brain Imaging and Behavior - Oxytocin is both a hormone and a neurotransmitter and has been originally recognized for its role in childbirth and lactation. Later, it became widely known as a... 相似文献
5.
6.
7.
Robert J. Motzer MD Bernard Escudier MD Saby George MD Hans J. Hammers MD PhD Sandhya Srinivas MD Scott S. Tykodi MD PhD Jeffrey A. Sosman MD Elizabeth R. Plimack MD Giuseppe Procopio MD David F. McDermott MD Daniel Castellano MD Toni K. Choueiri MD Frede Donskov MD PhD Howard Gurney MD Stéphane Oudard MD Martin Richardet MD PhD Katriina Peltola MD PhD Ajjai S. Alva MD Michael Carducci MD John Wagstaff MD Christine Chevreau MD Satoshi Fukasawa MD Yoshihiko Tomita MD PhD Thomas C. Gauler MD Christian K. Kollmannsberger MD Fabio A. Schutz PhD James Larkin MD PhD David Cella PhD M. Brent McHenry PhD Shruti Shally Saggi BEng Nizar M. Tannir MD 《Cancer》2020,126(18):4156-4167
8.
Vinke Jeroen Kaper Hans J. Vissink Arjan Sharma Prashant K. 《Clinical oral investigations》2020,24(11):4019-4030
Clinical Oral Investigations - The aims of this study are to assess different saliva substitutes for their efficacy to lubricate the oral cavity, and to relate this oral lubrication to the ability... 相似文献
9.
10.
Thomas Asendorf Robin Henderson Heinz Schmidli Tim Friede 《Statistics in medicine》2019,38(9):1503-1528
In some diseases, such as multiple sclerosis, lesion counts obtained from magnetic resonance imaging (MRI) are used as markers of disease progression. This leads to longitudinal, and typically overdispersed, count data outcomes in clinical trials. Models for such data invariably include a number of nuisance parameters, which can be difficult to specify at the planning stage, leading to considerable uncertainty in sample size specification. Consequently, blinded sample size re-estimation procedures are used, allowing for an adjustment of the sample size within an ongoing trial by estimating relevant nuisance parameters at an interim point, without compromising trial integrity. To date, the methods available for re-estimation have required an assumption that the mean count is time-constant within patients. We propose a new modeling approach that maintains the advantages of established procedures but allows for general underlying and treatment-specific time trends in the mean response. A simulation study is conducted to assess the effectiveness of blinded sample size re-estimation methods over fixed designs. Sample sizes attained through blinded sample size re-estimation procedures are shown to maintain the desired study power without inflating the Type I error rate and the procedure is demonstrated on MRI data from a recent study in multiple sclerosis. 相似文献